Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Hydroxychloroquine calms an overactive immune system by altering cell chemistry at the molecular level—explaining its real, proven roles and its limits.
Two long-established drugs from entirely different families, briefly paired in the headlines. Here is what each actually does, and why combining them requires real medical caution.
A close look at what clinical evidence actually shows about hydroxychloroquine use in children, during pregnancy and breastfeeding, and in older adults.
Hydroxychloroquine comes in one approved form, a 200mg oral tablet, yet salt-versus-base math, generic variation, and dosing all affect real-world results.
Hydroxychloroquine and albendazole treat entirely different conditions through unrelated mechanisms. Here is what each drug actually does and why comparing them head-to-head is mostly a category error.
Hydroxychloroquine is a mild, long-established DMARD used for rheumatoid arthritis, particularly milder disease or in combination with other drugs.
Hydroxychloroquine is widely prescribed for Sjögren's syndrome, but the largest placebo-controlled trial found no clear benefit for dryness or fatigue.
Hydroxychloroquine is the foundational, evidence-backed treatment for most people with lupus. Here is what the research actually shows, how it's dosed, and a realistic timeline for benefit.
Hydroxychloroquine treats lupus, rheumatoid arthritis, and some malaria strains by calming immune overactivity, not by curing infection outright.